Inogen | INGN - Operating Profit


Inogen reported $-7.79M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
Chart Industries USD 125.1M 52.4M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Philips EUR 719M 390M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
X T L Biopharmaceuticals USD -812K 48K Dec/2024
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026